FDA Adverse Event Injury Summary report: N

ISPAN PERFLUOROPROPANE (C3F8) GAS

MDR report key: 14509256 · Received May 26, 2022

Report

Report Number
1610287-2022-00037
Event Type
Injury
Date Received
May 26, 2022
Date of Event
February 10, 2022
Report Date
July 27, 2022
Manufacturer
AIRGAS THERAPEUTICS LLC
Product Code
LPO
UDI-DI
00380657971022
PMA / PMN Number
P900066
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

INVESTIGATION INCLUDING ROOT CAUSE ANALYSIS IS IN PROGRESS. A SUPPLEMENTAL MDR WILL BE FILED AS NECESSARY IN ACCORDANCE WITH 21 CFR 803.56 WHEN ADDITIONAL REPORTABLE INFORMATION BECOMES AVAILABLE. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).

Additional Manufacturer Narrative · 0

THE C3F8 [PERFLUOROPROPANE (PFP)] GAS TANK WAS NOT RETURNED FOR EVALUATION. A CHECK OF THE BATCH PRODUCTION RECORD FOR LOT SHOWED NO UNUSUAL MANUFACTURING ISSUES. A CHECK OF THE COMPLAINT RECORDS SHOWED SEVEN OTHER COMPLAINTS AGAINST LOTS. NO SAMPLE WAS RETURNED FOR EVALUATION. AN ANALYSIS OF THE RETAIN SAMPLE FOR LOS, SHOWED THAT THE PRODUCT WAS PERFLUOROPROPANE (PFP) AND MET ALL RELEASE CRITERIA. THE ROOT CAUSE CANNOT BE DETERMINED CONCLUSIVELY. MANUFACTURE WILL CONTINUE TO MONITOR DATA FOR EVIDENCE OF ADVERSE TRENDING AND TAKE FURTHER ACTION, AS APPROPRIATE. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).

Description of Event or Problem · 0

A CLINICAL STUDY REPORT STATING THAT AFTER USING THE PERFLUOROPROPANE GAS THE PATIENT WAS EXPERIENCED WITH ELEVATED INTRAOCULAR PRESSURE . MEDICAL TREATMENT WAS PROVIDED AND SYMPTOMS WERE IMPROVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2030193 ISPAN PERFLUOROPROPANE (C3F8) GAS INTRAOCULAR GAS LPO AIRGAS THERAPEUTICS LLC NA 034914 00380657971022

Patients

Seq Age Sex Outcome Treatment
1 Unknown Other| R